https://www.sciencedaily.com/releases/2022/10/221021093746.htm
0
0
10/21/22 at 5:56pm
Organization
Science Daily
47 words
0
Comments
A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to new study.
You are the first to view
Create an account
or login to join the discussion